Table 1.
Characteristics of patients n (%)
| PAC group | PAM group | Sequential | Concomitant | P value | |
| (n = 170) | (n = 170) | (n = 170) | (n = 170) | ||
| Age, yr | 55.6 ± 13.6 | 57.4 ± 12.8 | 58.3 ± 12.3 | 55.8 ± 12.6 | 0.1031 |
| Gender | 0.0602 | ||||
| Male | 102 (60.0) | 107 (62.9) | 110 (64.7) | 106 (62.4) | |
| Female | 68 (40.0) | 63 (37.1) | 60 (35.3) | 64 (37.7) | |
| Diagnosis | 0.5532 | ||||
| Gastric ulcer | 81 (47.7) | 77 (45.3) | 86 (50.6) | 78 (45.9) | |
| Duodenal ulcer | 36 (21.2) | 28 (16.5) | 32 (18.8) | 27 (15.9) | |
| Gastritis | 53 (31.2) | 65 (38.2) | 52 (30.6) | 65 (38.2) |
1
1-way ANOVA test;
2
χ2 test. PAC: Rabeprazole, amoxicillin and clarithromycin; PAM: Rabeprazole, amoxicillin and metronidazole.